Novakand Pharma AB (publ) (FRA:3EE0)
Germany
· Delayed Price · Currency is EUR 0.0001
0.00 (0.00%)
At close: Dec 5, 2025
Novakand Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | - | - | - | - | - | 0.09 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -97.20% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 0.03 | Upgrade
|
| Gross Profit | - | - | - | - | - | 0.06 | Upgrade
|
| Selling, General & Admin | 6.23 | 6.22 | 8.09 | 7.08 | 4.33 | 5.54 | Upgrade
|
| Research & Development | 28.28 | 39.95 | 57.99 | 45.61 | 42.63 | 39.28 | Upgrade
|
| Other Operating Expenses | -0.01 | -0.01 | - | - | -0 | -0.13 | Upgrade
|
| Operating Expenses | 34.5 | 46.16 | 66.08 | 52.69 | 46.96 | 44.69 | Upgrade
|
| Operating Income | -34.5 | -46.16 | -66.08 | -52.69 | -46.96 | -44.62 | Upgrade
|
| Interest Expense | - | - | - | -0.12 | -0.02 | -1.1 | Upgrade
|
| Interest & Investment Income | 0.59 | 1.6 | 0.28 | 0.07 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.45 | -0.09 | -0.25 | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | 0.46 | 0.34 | 1.54 | 2.35 | Upgrade
|
| EBT Excluding Unusual Items | -33.9 | -44.57 | -64.89 | -52.48 | -45.69 | -43.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 2.76 | Upgrade
|
| Pretax Income | -51.9 | -44.57 | -64.89 | -52.48 | -45.69 | -40.5 | Upgrade
|
| Net Income | -51.9 | -44.57 | -64.89 | -52.48 | -45.69 | -40.5 | Upgrade
|
| Net Income to Common | -51.9 | -44.57 | -64.89 | -52.48 | -45.69 | -40.5 | Upgrade
|
| Shares Outstanding (Basic) | 121 | 115 | 80 | 58 | 56 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 121 | 115 | 80 | 58 | 56 | 36 | Upgrade
|
| Shares Change (YoY) | 17.04% | 44.85% | 36.90% | 3.91% | 54.18% | 82.68% | Upgrade
|
| EPS (Basic) | -0.43 | -0.39 | -0.81 | -0.90 | -0.82 | -1.12 | Upgrade
|
| EPS (Diluted) | -0.43 | -0.39 | -0.81 | -0.90 | -0.82 | -1.12 | Upgrade
|
| Free Cash Flow | -35.66 | -58.53 | -55.67 | -47.56 | -44.13 | -38.99 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.51 | -0.70 | -0.82 | -0.79 | -1.07 | Upgrade
|
| Gross Margin | - | - | - | - | - | 70.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -49580.00% | Upgrade
|
| Profit Margin | - | - | - | - | - | -45000.00% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -43320.00% | Upgrade
|
| EBITDA | - | -43.16 | -63.08 | -52.33 | -46.64 | -43.05 | Upgrade
|
| D&A For EBITDA | - | 3 | 3 | 0.36 | 0.32 | 1.58 | Upgrade
|
| EBIT | -34.5 | -46.16 | -66.08 | -52.69 | -46.96 | -44.62 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.